<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39290506</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-1769</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in veterinary science</Title><ISOAbbreviation>Front Vet Sci</ISOAbbreviation></Journal><ArticleTitle>A sensitive and robust analytical method for the determination of enramycin residues in swine tissues using UHPLC-MS/MS.</ArticleTitle><Pagination><StartPage>1462743</StartPage><MedlinePgn>1462743</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1462743</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fvets.2024.1462743</ELocationID><Abstract><AbstractText>Enramycin, a common growth promoter utilized in chickens and pigs, is sensitive against Gram-positive bacteria, and the maximum residue limit (MRL) of enramycin set up by is 30 μg/kg. However, the methods have been reported for detecting enramycin have failed to meet the accuracy requirements, with the required limit of quantification being higher than the MRL. To address this issue, we developed a high-sensitive and robust analytical method based on ultrahigh-performance liquid chromatography coupled with mass spectrometry (UHPLC-MS/MS), to determine enramycin residues in swine tissues, including liver, kidney, pork, and fat. The ENV cartridge was selected to cleanup and enrich analytes after being extracted using a mixture of 55% methanol containing 0.2 M hydrochloric acid. With comprehensively validation, this established method was found great linearity of enramycin in each tissue, with a coefficient of variation above 0.99. Satisfactory recoveries from four different spiking levels were acquired (70.99-101.40%) while the relative standard deviations were all below 9%. The limit of quantification of enramycin in the present study is 5 μg/kg in fat and 10 μg/kg in other tissues, meeting the requirements for conducting the corresponding safety evaluation study. This method was demonstrated with excellent specificity, stability, and high sensitivity. To conclude, this novel approach is sufficiently sensitive and robust for the safety evaluation of enramycin in food products.</AbstractText><CopyrightInformation>Copyright © 2024 Sun, Qiu, Kong, Cao, Li and Cao.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Sun</LastName><ForeName>Feifei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Animal-Derived Food Safety Innovation Team, College of Animal Science and Technology, Anhui Agricultural University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Qiu</LastName><ForeName>Jicheng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Veterinary Pharmacology and Toxicology, China Agricultural University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Detection for Veterinary Drug Residue and Illegal Additive, Ministry of Agriculture, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Jingyuan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Veterinary Pharmacology and Toxicology, China Agricultural University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Detection for Veterinary Drug Residue and Illegal Additive, Ministry of Agriculture, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yuying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Veterinary Pharmacology and Toxicology, China Agricultural University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Detection for Veterinary Drug Residue and Illegal Additive, Ministry of Agriculture, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Animal-Derived Food Safety Innovation Team, College of Animal Science and Technology, Anhui Agricultural University, Hefei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Xingyuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Veterinary Pharmacology and Toxicology, China Agricultural University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Detection for Veterinary Drug Residue and Illegal Additive, Ministry of Agriculture, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Vet Sci</MedlineTA><NlmUniqueID>101666658</NlmUniqueID><ISSNLinking>2297-1769</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">UHPLC–MS/MS</Keyword><Keyword MajorTopicYN="N">enramycin</Keyword><Keyword MajorTopicYN="N">polypeptide antibiotic</Keyword><Keyword MajorTopicYN="N">residue</Keyword><Keyword MajorTopicYN="N">validation</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>18</Day><Hour>4</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39290506</ArticleId><ArticleId IdType="pmc">PMC11405371</ArticleId><ArticleId IdType="doi">10.3389/fvets.2024.1462743</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Higashide E, Hatano K, Shibata M, Nakazawa K. Enduracidin, a new antibiotic. I. Streptomyces fungicidicus no. B5477, an enduracidin producing organism. J Antibiot. (1968) 21:126–37.</Citation><ArticleIdList><ArticleId IdType="pubmed">5674368</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto S, Kuwahara S, Okubo N, Zenyoji H. In vitro and in vivo evaluation of enduracidin, a new peptide antibiotic substance. J Antibiot. (1968) 21:119–25. doi: 10.7164/antibiotics.21.119, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7164/antibiotics.21.119</ArticleId><ArticleId IdType="pubmed">4299887</ArticleId></ArticleIdList></Reference><Reference><Citation>Yourassowsky E, Monsieur R. In vitro and in vivo activity of enduracidin on Staphylococcus aureus. Chemotherapy. (1972) 17:182–7. doi: 10.1159/000220852</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000220852</ArticleId><ArticleId IdType="pubmed">5034722</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami M, Nagai Y, Fujii T, Mitsuhashi S. Anti-microbial activities of enduracidin (enramycin) in vitro and in vivo. J Antibiot (Tokyo). (1971) 24:583–6. doi: 10.7164/antibiotics.24.583, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7164/antibiotics.24.583</ArticleId><ArticleId IdType="pubmed">5132246</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchiya K, Kondo M, Oishi T, Yamazaki I. Enduracidin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity. J Antibiot. (1968) 21:147–53. doi: 10.7164/antibiotics.21.147, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7164/antibiotics.21.147</ArticleId><ArticleId IdType="pubmed">4386300</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Tiyanont K, Zhang Y, Wanner J, Boger D, Walker S. The mechanism of action of ramoplanin and enduracidin. Mol BioSyst. (2006) 2:69–76. doi: 10.1039/B515328J, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/B515328J</ArticleId><ArticleId IdType="pubmed">16880924</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Helm JS, Chen L, Ye XY, Walker S. Ramoplanin inhibits bacterial transglycosylases by binding as a dimer to lipid II. J Am Chem Soc. (2003) 125:8736–7. doi: 10.1021/ja035217i, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja035217i</ArticleId><ArticleId IdType="pubmed">12862463</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye XY, Lo MC, Brunner L, Walker D, Kahne D, Walker S. Better substrates for bacterial transglycosylases. J Am Chem Soc. (2001) 123:3155–6. doi: 10.1021/ja010028q</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja010028q</ArticleId><ArticleId IdType="pubmed">11457035</ArticleId></ArticleIdList></Reference><Reference><Citation>Food Safety Commission of Japan . Enramycin used for food producing animals: risk of antimicrobial-resistant bacteria: summary. Food Safety. (2015) 3:34–35. doi: 10.14252/foodsafetyfscj.2015004</Citation><ArticleIdList><ArticleId IdType="doi">10.14252/foodsafetyfscj.2015004</ArticleId></ArticleIdList></Reference><Reference><Citation>Horie M, Hoshino Y, Nose N, Nakazawa H, Fuiita M, Takabatake E. Determination of enramycin in chicken and swine muscles by high-performance liquid-chromatography. J Food Hyg Soc Jpn. (1985) 26:337–342_1. doi: 10.3358/shokueishi.26.337</Citation><ArticleIdList><ArticleId IdType="doi">10.3358/shokueishi.26.337</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue K, Hattori Y, Hino T, Oka H. An approach to on-line electrospray mass spectrometric detection of polypeptide antibiotics of enramycin for high-speed counter-current chromatographic separation. J Pharmaceut Biomed Anal. (2010) 51:1154–60. doi: 10.1016/j.jpba.2009.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2009.11.010</ArticleId><ArticleId IdType="pubmed">20004073</ArticleId></ArticleIdList></Reference><Reference><Citation>Boison JO, Lee S, Matus J. A multi-residue method for the determination of seven polypeptide drug residues in chicken muscle tissues by LC-MS/MS. Anal Bioanal Chem. (2015) 407:4065–78. doi: 10.1007/s00216-015-8644-z, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-015-8644-z</ArticleId><ArticleId IdType="pubmed">25832483</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X, Chen G, Qian Y, Fang J, Zhang M, Mao S, et al. . Development of a new monoclonal antibody by more active enramycin a and indirect competitive ELISA for the detection of enramycin in edible animal tissues. Food Anal Methods. (2019) 12:1895–904. doi: 10.1007/s12161-019-01504-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12161-019-01504-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S, Kim M, Kim C, Hwang JK, Kang W. Quantitative determination of xanthorrhizol in rat plasma by HPLC-MS/MS and its application to a pharmacokinetic study. J Pharm Biomed Anal. (2017) 132:56–9. doi: 10.1016/j.jpba.2016.09.043, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2016.09.043</ArticleId><ArticleId IdType="pubmed">27693953</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Choi S, Noh K, Kim C, Kim E, Hwang JK, et al. . Determination of panduratin a in rat plasma by HPLC-MS/MS and its application to a pharmacokinetic study. J Pharm Biomed Anal. (2017) 137:151–4. doi: 10.1016/j.jpba.2017.01.027, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2017.01.027</ArticleId><ArticleId IdType="pubmed">28119213</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y, Huang MQ, Xia YQ, Jemal M. High-throughput quantitation of nefazodone and its metabolites in human plasma by high flow direct-injection LC-MS/MS. J Pharm Biomed Anal. (2007) 43:1808–19. doi: 10.1016/j.jpba.2006.11.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2006.11.041</ArticleId><ArticleId IdType="pubmed">17236738</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Kandoussi H, Zeng J, Wang J, Demers R, Eley T, et al. . Multiplexed LC-MS/MS method for the simultaneous quantitation of three novel hepatitis C antivirals, daclatasvir, asunaprevir, and beclabuvir in human plasma. J Pharm Biomed Anal. (2015) 107:409–18. doi: 10.1016/j.jpba.2015.01.027, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2015.01.027</ArticleId><ArticleId IdType="pubmed">25676854</ArticleId></ArticleIdList></Reference><Reference><Citation>Daumar P, Dufour R, Dubois C, Penault-Llorca F, Bamdad M, Mounetou E. Development and validation of a high-performance liquid chromatography method for the quantitation of intracellular PARP inhibitor Olaparib in cancer cells. J Pharm Biomed Anal. (2018) 152:74–80. doi: 10.1016/j.jpba.2018.01.036, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2018.01.036</ArticleId><ArticleId IdType="pubmed">29414021</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrales-Rico A, Ramos Y, Besada V, Del Carmen Dominguez M, Lorenzo N, Garcia O, et al. . Development and validation of a bioanalytical method based on LC-MS/MS analysis for the quantitation of CIGB-814 peptide in plasma from rheumatoid arthritis patients. J Pharm Biomed Anal. (2017) 143:130–40. doi: 10.1016/j.jpba.2017.05.030, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2017.05.030</ArticleId><ArticleId IdType="pubmed">28595106</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency . ICH guideline M10 on bioanalytical method validation and study sample analysis, EMA/CHMP/ICH/172948/2019, (2019). 1–45. Available at: https://www.ema.europa.eu/en/ich-m10-bioanalytical-method-validation-scientific-guideline</Citation></Reference><Reference><Citation>Wu I-L, Turnipseed SB, Andersen WC, Madson MR. Analysis of peptide antibiotic residues in milk using liquid chromatography-high resolution mass spectrometry (LC-HRMS). Food Addit Contam A. (2020) 37:1264–78. doi: 10.1080/19440049.2020.1766703, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19440049.2020.1766703</ArticleId><ArticleId IdType="pmc">PMC11002982</ArticleId><ArticleId IdType="pubmed">32522108</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>